In a phase 3 trial, Tenpoint Therapeutics’ eye drop—a combination of carbachol and brimonidine—improved vision for patients ...

The Drugs Controller General of India (DCGI) has granted approval to Entod Pharmaceuticals’ innovative PresVu eye drops, ...

A novel presbyopia drop improves near vision using pupillary constriction to create a pinhole effect, while allowing good distance vision.

Patients with presbyopia experienced improvements in near vision after treatment with Brimochol PF in a second phase 3 ...

"PresVu emerges as the first-of-its-kind eye drop in India designed to eliminate the need for reading glasses among ...

Tenpoint Therapeutics, Inc., a global, clinical-stage biotech company developing groundbreaking treatments to rejuvenate ...

Now, there could be another alternative, in the form of eye drops administered daily ... for people newly-diagnosed with mild-to-moderate presbyopia, or as an adjunct to reading glasses for ...

But innovative new eye drops could soon do the trick ... hyperopia (farsightedness), myopia (nearsightedness), and presbyopia (age-related blurriness). Each of these disorders causes refractive ...

PresVu treats presbyopia patients by constricting pupils to see objects up close. A drop of PresVu claims to work within 15 minutes and last up to 6 hours. Second drop within 3 to 6 hours of the first ...

BRIMOCHOL PF, a presbyopia-correcting eye drop, combines carbachol and brimonidine, aiming for NDA approval by 2025. The merger includes Tenpoint’s TPT-161 for cataracts and TPT-005 for geographic ...

India's medical fraternity drove creative and cost-effective innovations, making 2024 a landmark year for medical ...